Marijuana use associations with pulmonary symptoms and function in Tobacco smokers enrolled in the Subpopulations and Intermediate Outcome Measures in COPD study (SPIROMICS)

Madeline A. Morris, Sean R. Jacobson, Gregory L. Kinney, Donald P. Tashkin, Prescott G. Woodruff, Eric A. Hoffman, Richard E. Kanner, Christopher B. Cooper, M. Brad Drummond, R. Graham Barr, Elizabeth C. Oelsner, Barry J. Make, Mei Lan K. Han, Nadia N. Hansel, Wanda K. O'Neal, Russell P. Bowler

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Marijuana is often smoked via a filterless cigarette and contains similar chemical makeup as smoked tobacco. There are few publications describing usage patterns and respiratory risks in older adults or in those with chronic obstructive pulmonary disease (COPD). Methods: A cross-sectional analysis of current and former tobacco smokers from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) study assessed associations between marijuana use and pulmonary outcomes. Marijuana use was defined as never, former (use over 30 days ago), or current (use within 30 days). Respiratory health was assessed using quantitative high-resolution computed tomography (HRCT) scans, pulmonary function tests and questionnaire responses about respiratory symptoms. Results: Of the total 2304 participants, 1130 (49%) never, 982 (43%) former, and 192 (8%) current marijuana users were included. Neither current nor former marijuana use was associated with increased odds of wheeze (odds ratio [OR] 0.87, OR 0.97), cough (OR 1.22; OR 0.93) or chronic bronchitis (OR 0.87; OR 1.00) when compared to never users. Current and former marijuana users had lower quantitative emphysema (P=0.004, P=0.03), higher percent predicted forced expiratory volume in 1 second (FEV1%) (P < 0.001, P < 0.001), and percent predicted forced vital capacity (FVC%) (p < 0.001, P < 0.001). Current marijuana users exhibited higher total tissue volume (P=0.003) while former users had higher air trapping (P < 0.001) when compared to never marijuana users. Conclusions: Marijuana use was found to have little to no association with poor pulmonary health in older current and former tobacco smokers after adjusting for covariates. Higher forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) was observed among current marijuana users. However, higher joint years was associated with more chronic bronchitis symptoms (e.g., wheeze), and this study cannot determine if long-term heavy marijuana smoking in the absence of tobacco smoking is associated with lung symptoms, airflow obstruction, or emphysema, particularly in those who have never smoked tobacco cigarettes.

Original languageEnglish (US)
Pages (from-to)46-56
Number of pages11
JournalChronic Obstructive Pulmonary Diseases
Volume5
Issue number1
DOIs
StatePublished - 2018

Keywords

  • Chronic obstructive pulmonary disease
  • Computed tomography scan
  • Cross-sectional
  • Emphysema
  • Epidemiology
  • Forced expiratory volume
  • Forced vital capacity
  • Lung
  • Marijuana
  • Pulmonary
  • Respiratory
  • Smoking
  • Tobacco

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Marijuana use associations with pulmonary symptoms and function in Tobacco smokers enrolled in the Subpopulations and Intermediate Outcome Measures in COPD study (SPIROMICS)'. Together they form a unique fingerprint.

Cite this